Chung-Chun Wu - Search Results

Year	Number of Results
2004	1
2005	1
2008	1
2009	3
2010	1
2012	2
2013	2
2014	2
2015	1
2016	2
2017	4
2018	1
2019	1
2020	1
2022	1
2023	2
2024	2

1

BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors.

Huang SW, Pan CM, Lin YC, Chen MC, Chen Y, Jan CI, Wu CC, Lin FY, Wang ST, Lin CY, Lin PY, Huang WH, Chiang YT, Tsai WC, Chiu YH, Lin TH, Chiu SC, Cho DY. Huang SW, et al. Among authors: wu cc. Adv Sci (Weinh). 2023 Jun;10(17):e2206856. doi: 10.1002/advs.202206856. Epub 2023 Apr 20. Adv Sci (Weinh). 2023. PMID: 37078788 Free PMC article.

2

The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy.

Wu CC, Chen MS, Chen JY. Wu CC, et al. Biomedicines. 2024 Feb 21;12(3):486. doi: 10.3390/biomedicines12030486. Biomedicines. 2024. PMID: 38540100 Free PMC article. Review.

3

The Dietary Flavonol Kaempferol Inhibits Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells.

Wu CC, Lee TY, Cheng YJ, Cho DY, Chen JY. Wu CC, et al. Molecules. 2022 Nov 23;27(23):8158. doi: 10.3390/molecules27238158. Molecules. 2022. PMID: 36500249 Free PMC article.

4

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis.

Wu CC, Chen MS, Cheng YJ, Ko YC, Lin SF, Chiu IM, Chen JY. Wu CC, et al. Cancers (Basel). 2019 Nov 15;11(11):1795. doi: 10.3390/cancers11111795. Cancers (Basel). 2019. PMID: 31731581 Free PMC article.

5

Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions.

Wu CC, Chen MS, Lee TY, Cheng YJ, Tsou HH, Huang TS, Cho DY, Chen JY. Wu CC, et al. Virol J. 2023 Jul 13;20(1):148. doi: 10.1186/s12985-023-02107-x. Virol J. 2023. PMID: 37443068 Free PMC article.

6

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.

Wu CC, Fang CY, Cheng YJ, Hsu HY, Chou SP, Huang SY, Tsai CH, Chen JY. Wu CC, et al. J Biomed Sci. 2017 Jan 5;24(1):2. doi: 10.1186/s12929-016-0313-9. J Biomed Sci. 2017. PMID: 28056971 Free PMC article.

7

Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.

Wu CC, Chen MS, Lee TY, Huang TS, Cho DY, Chen JY. Wu CC, et al. Viral Immunol. 2024 Mar;37(2):115-123. doi: 10.1089/vim.2023.0118. Viral Immunol. 2024. PMID: 38498796

8

EBV reactivation as a target of luteolin to repress NPC tumorigenesis.

Wu CC, Fang CY, Hsu HY, Chuang HY, Cheng YJ, Chen YJ, Chou SP, Huang SY, Lin SF, Chang Y, Tsai CH, Chen JY. Wu CC, et al. Oncotarget. 2016 Apr 5;7(14):18999-9017. doi: 10.18632/oncotarget.7967. Oncotarget. 2016. PMID: 26967558 Free PMC article.

9

Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.

Ko YC, Lai TY, Hsu SC, Wang FH, Su SY, Chen YL, Tsai ML, Wu CC, Hsiao JR, Chang JY, Wu YM, Robinson DR, Lin CY, Lin SF. Ko YC, et al. Among authors: wu cc. Cancers (Basel). 2020 Jun 28;12(7):1718. doi: 10.3390/cancers12071718. Cancers (Basel). 2020. PMID: 32605311 Free PMC article.

10

Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.

Wu CC, Fang CY, Huang SY, Chiu SH, Lee CH, Chen JY. Wu CC, et al. Cancers (Basel). 2018 Apr 17;10(4):120. doi: 10.3390/cancers10040120. Cancers (Basel). 2018. PMID: 29673164 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year